$5.55
0.316.02%
Last update: Oct 13, 9:28 AM
$5.55
0.316.02%
Clinuvel Pharmaceuticals Ltd (CUVL) Stock Price, Quote, News & History
CUVLNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Clinuvel Pharmaceuticals Ltd is a biopharmaceutical firm focused on developing and delivering therapies for patients with genetic, metabolic, and dermatological disorders. Its portfolio is centred around melanocortin peptides, with programs advancing...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Clinuvel Pharmaceuticals (NASDAQ:CUVL) through any online brokerage.
Other companies in Clinuvel Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
There is no analysis for Clinuvel Pharmaceuticals to provide a consensus price target.
The stock price for Clinuvel Pharmaceuticals (NASDAQ: CUVL) is $5.55 last updated October 13, 2026 at 9:28 AM EDT.
There are no upcoming dividends for Clinuvel Pharmaceuticals.
Clinuvel Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Clinuvel Pharmaceuticals.
Clinuvel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
